Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 597
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | ||
| NCT01842646 | Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) | ||
| NCT05496686 | Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma | ||
| NCT05664178 | Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology | ||
| NCT00495625 | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | ||
| NCT00360685 | Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX | ||
| NCT00215943 | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | ||
| NCT02611037 | Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma | ||
| NCT03598309 | Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers | ||
| NCT01133275 | Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS | ||
| NCT00665002 | Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms | ||
| NCT02061007 | Biomarker Correlates of Hypoxia in Metastatic Melanoma | ||
| NCT03295695 | PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient | ||
| NCT05677360 | HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) | ||
| NCT06435351 | Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy | ||
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | ||
| NCT02440425 | Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer | ||
| NCT03176576 | Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population | ||
| NCT03177291 | Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | ||
| NCT05649969 | STRONG Program for Cancer Patients | ||
| NCT07222995 | Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs | ||
| NCT01350583 | Bicarbonate for Tumor Related Pain | ||
| NCT01385956 | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer | ||
| NCT04745559 | Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy | ||
| NCT00082641 | Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer | ||
| NCT06560398 | Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S) | ||
| NCT00831766 | Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | ||
| NCT00012350 | Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | ||
| NCT07357298 | Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer | ||
| NCT05316116 | Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) | ||
| NCT01534078 | Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma | ||
| NCT00006376 | R115777 in Treating Patients With Advanced Bladder Cancer | ||
| NCT02186834 | Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma | ||
| NCT03628144 | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer | ||
| NCT04052334 | Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT03614949 | SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | ||
| NCT00948922 | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | ||
| NCT02115542 | Single Agent Regorafenib in Refractory Advanced Biliary Cancers | ||
| NCT02292173 | Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer | ||
| NCT03734666 | Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation | ||
| NCT01437605 | Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC | ||
| NCT02586675 | TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer | ||
| NCT05233228 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | ||
| NCT03514017 | Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia | ||
| NCT01324180 | Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01176461 | Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558 | ||
| NCT04741997 | Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma | ||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT04150874 | Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE |
